google-site-verification=xFUDWxW5PP9Xl26LgFIMNKYgPbsh1LWfAMqfAHDkhIM Potential of SARS-CoV-2 in Cancer Development: A Hypothetical and Mechanistic View - Research in Molecular Medicine
Volume 12, Issue 2 (May 2024)                   Res Mol Med (RMM) 2024, 12(2): 0-0 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rahimlou M E, Rahimlou E, Shakibfar F, Fathi Maroufi N. Potential of SARS-CoV-2 in Cancer Development: A Hypothetical and Mechanistic View. Res Mol Med (RMM) 2024; 12 (2)
URL: http://rmm.mazums.ac.ir/article-1-582-en.html
1- , n.fathi6788@gmail.com
Abstract:   (534 Views)
The COVID-19 pandemic caused by the SARS-CoV-2 virus can lead to long-term health effects, such as possible oncogenic properties. The evidence shows that SARS-CoV-2 may affect cellular pathways involved in cancer development, such as chronic inflammation, immune evasion, and genomic instability. This review study explores the hypothetical mechanisms by which SARS-CoV-2 contributes to oncogenesis, including persistent viral infection, dysregulation of tumor suppressor genes (e.g. p53), activation of pro-oncogenic signaling (e.g. NF-κB, JAK/STAT), and induction of long-term oxidative stress. While the evidence of the link between SARS-CoV-2 and cancer remains limited, like other oncogenic viruses, including HPV and EBV, further investigation is needed. Further epidemiological and molecular studies are needed to validate these hypotheses and assess the potential oncogenic impact of SARS-CoV-2.
Keywords: COVID 19, Cancer, SARS-CoV-2
Full-Text [PDF 642 kb]   (102 Downloads)    
Type of Study: review | Subject: Immunology
Published: 2024/05/21

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

Designed & Developed by : Yektaweb